MARKET

IBIO

IBIO

IBIO
AMEX

Real-time Quotes | Nasdaq Last Sale

0.1525
-0.0045
-2.87%
After Hours: 0.1601 +0.0076 +4.98% 17:21 11/12 EST
OPEN
0.1643
PREV CLOSE
0.1570
HIGH
0.1699
LOW
0.1510
VOLUME
544.88K
TURNOVER
--
52 WEEK HIGH
1.400
52 WEEK LOW
0.1510
MARKET CAP
4.06M
P/E (TTM)
-0.1615
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of IBIO and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

IBIO News

  • IBio down 49% after pricing equity offering
  • seekingalpha.10/25 18:02
  • iBio, Inc. Prices $5,000,000 Public Offering
  • GlobeNewswire.10/25 13:30
  • iBio Prices $5M Offering
  • Benzinga.10/25 12:33
  • iBio, Inc. Reports on NYSE American Noncompliance Notice and Compliance Plan
  • GlobeNewswire.10/22 21:30

More

Industry

Pharmaceuticals
+0.28%
Pharmaceuticals & Medical Research
+0.31%

Hot Stocks

Name
Price
%Change

About IBIO

iBio, Inc. is a biotechnology company. The Company is focused on commercializing its technologies and product candidates and providing product development and manufacturing services to clients and collaborators. Its technologies include iBioLaunch technology and iBioModulator. The Company's technologies constitute a transformative platform for development and production of biologics in hydroponically grown green plants. The Company is focused on the commercialization of its plant-based protein expression technologies for vaccines and therapeutic proteins and on developing and commercializing select biopharmaceutical product candidates. The Company's technology is applicable in a range of product candidates, including products against fibrotic diseases, vaccines, enzyme replacements, monoclonal antibodies, and recombinant versions of marketed products that are derived from human blood plasma.
More

Webull offers Ibio Inc (IBIO) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.